NeoStem Raises Additional Funds from Principals of Suzhou Erye Pharmaceuticals Company Ltd. and U.S. Institutional and Private Investors, Bringing the Total Recent Financings to Over $15 Million; Funds Will Support Expansion Activities in the United States and China as well as Further Development of NeoStem's VSEL and other Licensed Technologies
SenesTech Announces New Vice President of Business Development
Gerresheimer Sells Technical Plastics Business
New Review on PROSTVAC(TM) Published by Key Investigators From NCI
Enigma Diagnostics Announces Successful Evaluation of the Enigma FL by the UK's Veterinary Laboratories Agency
Insmed Announces Addition to the Russell 3000(R) Index
Issuers of news releases and not PR Newswire are solely responsible for the accuracy of the content. Terms and conditions, including restrictions on redistribution, apply. Copyright © 1996-2009 PR Newswire Association LLC. All Rights Reserved. A United Business Media company.